Medicenna Therapeutics Corp.
MDNAF
$0.7212
-$0.0228-3.07%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 20.85M | 22.52M | 26.03M | 12.54M | 16.48M |
Total Receivables | 991.80K | 1.10M | 870.90K | 859.60K | 305.20K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 408.70K | 569.20K | 819.10K | 687.50K | 794.30K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 22.25M | 24.19M | 27.72M | 14.09M | 17.57M |
|
|||||
Total Current Assets | 22.25M | 24.19M | 27.72M | 14.09M | 17.57M |
Net Property, Plant & Equipment | 121.60K | 143.60K | 20.50K | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 36.80K | 40.00K | 40.20K | 42.10K | 43.90K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 22.41M | 24.37M | 27.78M | 14.13M | 17.62M |
|
|||||
Total Accounts Payable | 1.31M | 1.47M | 2.58M | 1.53M | 3.05M |
Total Accrued Expenses | 871.50K | 626.20K | 358.00K | 585.60K | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 27.80K | 23.70K | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | 8.12M | 8.18M | 464.20K |
Total Other Current Liabilities | -- | -- | 8.12M | 8.18M | 464.20K |
Total Current Liabilities | 2.21M | 2.12M | 11.06M | 10.30M | 3.51M |
|
|||||
Total Current Liabilities | 2.21M | 2.12M | 11.06M | 10.30M | 3.51M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 93.10K | 106.60K | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 7.98M | 7.30M | -- | -- | -- |
Total Liabilities | 10.28M | 9.53M | 11.06M | 10.30M | 3.51M |
|
|||||
Common Stock & APIC | 88.28M | 92.14M | 89.94M | 82.43M | 84.15M |
Retained Earnings | -83.01M | -84.57M | -80.43M | -78.61M | -70.07M |
Treasury Stock & Other | 6.86M | 7.27M | 7.21M | 14.00K | 30.30K |
Total Common Equity | 12.13M | 14.84M | 16.72M | 3.83M | 14.11M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 12.13M | 14.84M | 16.72M | 3.83M | 14.11M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 12.13M | 14.84M | 16.72M | 3.83M | 14.11M |
|